KRas G12C inhibitors
US10647715B2 · kind B2 · utility
6Cited by
4References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 14, 2019 |
| Grant date | May 12, 2020 |
| Priority date | — |
| Expiry date | May 14, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds that inhibit KRas G12C. In particular, the present invention relates to compounds that irreversibly inhibit the activity of KRas G12C, pharmaceutical compositions comprising the compounds and methods of use therefor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.